Roberto Russo Selected Research

Anaphylaxis (Anaphylactic Shock)

1/2022

Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Russo Research Topics

Disease

23	Inflammation (Inflammations) 01/2023 - 01/2005
19	Pain (Aches) 12/2021 - 01/2005
11	Neuralgia (Stump Neuralgia) 01/2022 - 11/2005
10	Neoplasms (Cancer) 01/2023 - 11/2003
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2017
6	Hyperalgesia 01/2022 - 06/2009
4	Edema (Dropsy) 05/2024 - 01/2005
3	COVID-19 07/2023 - 07/2021
3	Autistic Disorder (Autism) 12/2022 - 01/2018
3	Bullous Pemphigoid (Pemphigoid) 06/2022 - 06/2020
3	Seizures (Absence Seizure) 01/2021 - 11/2016
3	Absence Epilepsy (Childhood Absence Epilepsy) 01/2020 - 06/2013
3	Chronic Pain 01/2020 - 01/2016
3	Hypertension (High Blood Pressure) 04/2018 - 10/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 06/2012
3	Non-alcoholic Fatty Liver Disease 04/2016 - 01/2013
3	Insulin Resistance 04/2016 - 01/2013
2	Carcinoma (Carcinomatosis) 01/2023 - 03/2022
2	Atopic Dermatitis (Atopic Eczema) 06/2022 - 01/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2019
2	Hypersensitivity (Allergy) 01/2022 - 01/2022
2	Hemorrhage 01/2022 - 01/2018
2	Skin Diseases (Skin Disease) 12/2021 - 05/2016
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2020 - 04/2018
2	Chronic Renal Insufficiency 02/2020 - 07/2013
2	Epilepsy (Aura) 01/2020 - 11/2017
2	Facial Pain (Myofacial Pain) 11/2019 - 01/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 06/2019 - 07/2013
2	Body Weight (Weight, Body) 01/2019 - 11/2013
2	Secondary Hyperparathyroidism 04/2018 - 10/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 11/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 10/2014
2	Vitamin D Deficiency 10/2014 - 07/2013
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023
1	Overweight 01/2023

Drug/Important Bio-Agent (IBA)

14	palmidrolIBA 01/2022 - 01/2005
10	Analgesics (Analgesic Drugs)IBA 05/2024 - 07/2007
7	Butyric Acid (Butanoic Acid)IBA 01/2023 - 01/2013
7	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 06/2012
6	CarrageenanIBA 05/2024 - 01/2005
6	Butyrates (Butyrate)IBA 01/2022 - 01/2013
6	PPAR alphaIBA 12/2009 - 01/2005
5	EndocannabinoidsIBA 01/2023 - 07/2007
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2013
5	Formaldehyde (Formol)FDA Link 12/2021 - 12/2006
5	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2017
4	Therapeutic UsesIBA 01/2022 - 07/2013
4	CannabinoidsIBA 08/2021 - 11/2016
3	Volatile Fatty AcidsIBA 01/2023 - 01/2018
3	LipidsIBA 01/2018 - 08/2005
3	anandamide (arachidonylethanolamide)IBA 01/2018 - 07/2007
3	butyramideIBA 01/2017 - 01/2013
3	AmidesIBA 01/2013 - 01/2005
2	VaccinesIBA 07/2023 - 07/2021
2	Insulin (Novolin)FDA Link 01/2023 - 01/2014
2	AntibodiesIBA 03/2022 - 01/2022
2	LigandsIBA 01/2022 - 10/2013
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2022 - 01/2018
2	CytokinesIBA 01/2022 - 07/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2022
2	Phaseolus vulgaris alpha-amylase inhibitor (phaseolamin)IBA 01/2022 - 01/2019
2	SodiumIBA 02/2020 - 01/2017
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020 - 07/2007
2	Histone Deacetylase InhibitorsIBA 01/2020 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2020
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 01/2020
2	CholesterolIBA 01/2019 - 04/2016
2	Cholecalciferol (Vitamin D3)FDA Link 04/2018 - 10/2014
2	paricalcitol (Zemplar)FDA Link 04/2018 - 07/2013
2	N-acylethanolaminesIBA 01/2018 - 12/2009
2	Messenger RNA (mRNA)IBA 01/2018 - 04/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018 - 10/2010
2	ProdrugsIBA 01/2018 - 06/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 04/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 11/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2016 - 06/2013
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2016 - 06/2013
2	Antipsychotic Agents (Antipsychotics)IBA 07/2015 - 11/2013
2	Vitamin D FDA LinkGeneric 10/2014 - 07/2013
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2013 - 12/2006
2	AcidsIBA 12/2009 - 07/2007
2	NF-kappa B (NF-kB)IBA 06/2009 - 09/2007
2	GW 7647IBA 07/2007 - 12/2006
2	Ethanolamine (Colamine)IBA 08/2005 - 01/2005
2	Palmitic Acid (Hexadecanoic Acid)IBA 08/2005 - 01/2005
1	Acetic Acid (Vinegar)FDA LinkGeneric 05/2024
1	AmyloseIBA 01/2023
1	deflazacortIBA 01/2023
1	PropionatesIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	AzoxymethaneIBA 01/2023

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 11/2013
3	Oral Administration 10/2019 - 07/2007
3	Renal Dialysis (Hemodialysis) 06/2019 - 09/2012
3	Therapeutics 01/2017 - 10/2010
2	Continuous Ambulatory Peritoneal Dialysis (CAPD) 06/2019 - 11/2013
2	Peritoneal Dialysis 10/2014 - 11/2013
1	Palliative Care (Palliative Therapy) 01/2023